Ceryvyn Therapeutics-ADRCYVNY
13F holders, Q1 2024 (March 31)8holders
1famous investor
$4.11avg. 13F price*
At the end of Q1 2024, 8 institutions reported holding Ceryvyn Therapeutics-ADR (CYVNY) in their 13F filings. The largest holders were Regal Partners Ltd ($11.9M), Baker Bros. Advisors LP ($9.0M) and Victory Capital Management Inc. ($3.5M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Ceryvyn Therapeutics-ADR
- Filed as
- OPTHEA LTD (Q1 2024)
- CUSIP
- 68386J208
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $143K |
Ownership 8 holders
| Regal Partners Ltd | 1.20% | Add +0.4% | 2,907,403 | $11.9M |
| Baker Bros. Advisors LP | 0.11% | Reduce -15.9% | 2,177,826 | $9.0M |
| Victory Capital Management Inc. | 0.00% | Reduce -3.2% | 855,524 | $3.5M |
| Teacher Retirement System of Texas | 0.02% | No change | 625,000 | $2.6M |
| Millennium Management | 0.00% | Reduce -1.5% | 73,582 | $302K |
| Bank of Montreal | 0.00% | Add +29.0% | 53,191 | $223K |
| Frazier Financial Advisors, LLC | 0.00% | Add +57.8% | 355 | $1K |
| Morgan Stanley | 0.00% | Reduce -97.9% | 21 | $86 |
"% of holder's portfolio" is CYVNY's weight in each manager's 13F, not the share of Ceryvyn Therapeutics-ADR the manager owns.